Clinical Trial Update: Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

View source ↗

Summary

A prospective study evaluating patient-reported outcomes during rechallenge with trabectedin in soft tissue sarcoma patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Soft Tissue Sarcoma | Status: TERMINATED